Literature DB >> 32706972

The S100B Alarmin Is a Dual-Function Chaperone Suppressing Amyloid-β Oligomerization through Combined Zinc Chelation and Inhibition of Protein Aggregation.

Joana S Cristóvão1,2, António J Figueira1,2, Ana P Carapeto1,3, Mário S Rodrigues1,3, Isabel Cardoso4,5, Cláudio M Gomes1,2.   

Abstract

Amyloid beta (Aβ) aggregation and imbalance of metal ions are major hallmarks of Alzheimer's disease (AD). Indeed, amyloid plaques of AD patients are enriched in zinc and Aβ42, and AD related-cognitive decline is dependent on extracellular zinc concentration. In vitro, zinc induces the formation of polymorphic Aβ42 oligomers that delay the formation of amyloid fibers at the expense of increased cellular toxicity. S100B is an inflammatory alarmin and one of the most abundant proteins in the brain and is upregulated in AD and associated with amyloid plaques, where it exerts extracellular functions. Recent findings have uncovered novel neuroprotective functions for S100B as a suppressor of Aβ aggregation and toxicity and in the regulation of zinc homeostasis in neurons. Here we combine biophysical and kinetic approaches to demonstrate that such S100B protective functions converge, making the protein a dual-function chaperone capable of suppressing the formation of toxic Aβ oligomers through both chelation of zinc and inhibition of protein aggregation. From detailed kinetic analysis of Aβ42 aggregation monitoring ThT fluorescence, we show that substoichiometric S100B prevents the formation of toxic off-pathway oligomers that are formed by monomeric Aβ42 in the presence of zinc. Indeed, S100B is effective when added during the lag and transition phases of Aβ42 aggregation, and its action under these circumstances results from its ability to buffer zinc, as it perfectly mimics the effect obtained with the chelating agent EDTA. Further, bioimaging analysis combining transmission electron microscopy and atomic force microscopy confirms that catalytic amounts of S100B partly revert the formation of toxic oligomers. Taken together these results indicate a new role for S100B as a dual chaperone whose distinct functions are interrelated and depend on the relative levels of zinc, S100B, and Aβ, which dynamically evolve during AD.

Entities:  

Keywords:  Alzheimer’s disease; S100 proteins; aggregation kinetics; amyloid beta oligomers; metal ions; zinc-binding proteins

Mesh:

Substances:

Year:  2020        PMID: 32706972     DOI: 10.1021/acschemneuro.0c00392

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  6 in total

1.  Expanding the family of extracellular chaperones: Identification of human plasma proteins with chaperone activity.

Authors:  Nicholas J Geraghty; Sandeep Satapathy; Megan Kelly; Flora Cheng; Albert Lee; Mark R Wilson
Journal:  Protein Sci       Date:  2021-10-04       Impact factor: 6.725

2.  Targeting S100B with Peptides Encoding Intrinsic Aggregation-Prone Sequence Segments.

Authors:  Joana S Cristóvão; Mariana A Romão; Rodrigo Gallardo; Joost Schymkowitz; Frederic Rousseau; Cláudio M Gomes
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

Review 3.  Zinc in Cognitive Impairment and Aging.

Authors:  Ruize Sun; Jue Wang; Juan Feng; Bin Cao
Journal:  Biomolecules       Date:  2022-07-18

Review 4.  Role of micronutrients in Alzheimer's disease: Review of available evidence.

Authors:  Hong-Xin Fei; Chao-Fan Qian; Xiang-Mei Wu; Yu-Hua Wei; Jin-Yu Huang; Li-Hua Wei
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

5.  Computational Analysis of the Interactions between the S100B Extracellular Chaperone and Its Amyloid β Peptide Client.

Authors:  Filipe E P Rodrigues; António J Figueira; Cláudio M Gomes; Miguel Machuqueiro
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

6.  Dynamic interactions and Ca2+-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seeding.

Authors:  Guilherme G Moreira; François-Xavier Cantrelle; Andrea Quezada; Filipa S Carvalho; Joana S Cristóvão; Urmi Sengupta; Nicha Puangmalai; Ana P Carapeto; Mário S Rodrigues; Isabel Cardoso; Güenter Fritz; Federico Herrera; Rakez Kayed; Isabelle Landrieu; Cláudio M Gomes
Journal:  Nat Commun       Date:  2021-11-01       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.